"For those interested in self or caregiver administration, the vaccine manufacturer plans to make the vaccine available ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
The AstraZeneca vaccine FluMist, which is administered in nasal spray form, was first approved by the FDA in 2003 for people ...
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
No doctor? No problem. In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca's FluMist, which was ...
The nasal spray vaccine known as FluMist has been approved for over 20 years. It can be administered to individuals between 2 and 49 years of age. Nasal spray vaccines are considered a viable ...